Algorae Pharmaceuticals Ltd (LVCLF): LCT granted USA Patent for Auckland Isla...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	41
Posts	2953
Boards Moderated	4
Alias Born	05/19/2010

SJOGRINGO

Re: None

Tuesday, 02/28/2012 8:56:38 PM

Tuesday, February 28, 2012 8:56:38 PM

LCT granted USA Patent for Auckland Island Pigs

February 2012

Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that it has been granted U.S. Patent No. 8,088,969 from the United States Patent and Trademark Office (USPTO). The patent, which was issued on 3 January 2012 and expires on 10 November 2028, provides exclusive rights to the use of cells and tissue derived from Auckland Island pigs for xenotransplantation therapies. It protects the holder’s ability to commercialise therapies based on its core cell encapsulation and xenotransplantation capabilities.

Download PDF
http://www.lctglobal.com/html/blob.php/LCT%20granted%20USA%20Patent%20for%20Auckland%20Island%20Pigs.pdf?attach=0&documentCode=4272&elementId=20084u

Never buy or sell based on my posts.Always consult with a licensed securities professional before you buy or sell any security.My posts are opinions only.Never use them as due diligence.My positions are subject to change without notice.